|
| Exchange Disseminated Time 03/11/2016 09:33:03 | Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on November 12, 2016, inter alia, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2016 (Q2).
Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from November 05, 2016 to November 14, 2016 (both days inclusive) as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. |
|
|